Indoco Remedies Ltd. - Research Center
532612 INDOCO Group (B) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sales | 840.59 | 766.64 | 773.08 | 603.51 | 561.36 |
| Operating profit | 159.06 | 153.87 | 173.13 | 109.04 | 68.45 |
| Interest | 9.38 | 6.85 | 7.29 | 11.64 | 14.76 |
| Gross profit | 151.15 | 147.47 | 167.71 | 98.18 | 54.90 |
| EPS (Rs) | 9.56 | 7.96 | 8.42 | 4.59 | 1.60 |
Half yearly
results in details
| Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | Mar ' 20 | |
|---|---|---|---|---|---|
| Other income | 1.47 | 0.45 | 1.87 | 0.78 | 1.21 |
| Stock adjustment | 5.66 | -9.00 | -17.30 | -0.55 | -5.47 |
| Raw material | 194.12 | 211.42 | 182.20 | 139.62 | 128.99 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 163.01 | 143.89 | 148.52 | 140.42 | 130.82 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | 37.03 | 19.67 | - | - | -22.76 |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 281.71 | 246.79 | 286.53 | 214.98 | 261.33 |
| Provisions made | - | - | - | - | - |
| Depreciation | 35.75 | 37.26 | 41.69 | 37.70 | 35.78 |
| Taxation | 27.29 | 36.87 | 48.47 | 18.14 | 4.38 |
| Net profit / loss | 88.11 | 73.34 | 77.55 | 42.34 | 14.74 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 18.43 | 18.43 | 18.43 | 18.43 | 18.43 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 18.92 | 20.07 | 22.39 | 18.07 | 12.19 |
| GPM (%) | 17.95 | 19.22 | 21.64 | 16.25 | 9.76 |
| NPM (%) | 10.46 | 9.56 | 10.01 | 7.01 | 2.62 |
Mutual Fund Selector
Find the fund that is right for you
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis